Market research

ELYM Eliem Therapeutics Inc

NASDAQ USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

Market cap: 343M
P/E ratio: Not available
Analyst target: 4.5
Dividend yield: Not available
Beta: -0.38

Loading price history…

Profile

Company facts

Exchange: NASDAQ
Currency: USD
Sector: Healthcare
Industry: Biotechnology
ISIN: US28658R1068
Market cap: 343M
P/E ratio: Not available
Analyst target: 4.5
Dividend yield: Not available
Beta: -0.38

About

About Eliem Therapeutics Inc

Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.

Visit company website

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about ELYM.

ELYM Eliem Therapeutics Inc

Price & volume

Company facts

About Eliem Therapeutics Inc

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet